Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

236.31
Delayed Data
As of Aug 25
 -6.96 / -2.86%
Today’s Change
195.50
Today|||52-Week Range
322.68
-24.38%
Year-to-Date
Cempra's Application for Pneumonia Drug Validated in EU
Aug 24 / Zacks.com - Paid Partner Content
3 Stocks Billionaires Are Buying
Aug 23 / MotleyFool.com - Paid Partner Content
Dear Pfizer, Stop Overpaying for Acquisitions!
Aug 24 / MotleyFool.com - Paid Partner Content
Congress Demand An Explanation For Epipen Price Increases; Mylan Slides
Aug 22 / Investing Channel - Paid Partner Content
Which Criteria Best Determine the Success of Mergers?
Aug 24 / GuruFocus News - Paid Partner Content
Pfizer makes $14bn bet on cancer drugmaker Medivation
Aug 22 / FT.com - Paid Partner Content
5 Things You Must Know Before the Market Opens Wednesday
Aug 24 / TheStreet.com - Paid Partner Content
Pfizer/Medivation: combination therapy
Aug 22 / FT.com - Paid Partner Content
Pfizer Picks Up AstraZeneca's Antibiotics Business
Aug 24 / TheStreet.com - Paid Partner Content
Carl Icahn Buys Allergan
Aug 22 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close243.27
Today’s open243.00
Day’s range232.05 - 244.27
Volume6,131,921
Average volume (3 months)3,484,860
Market cap$96.3B
Dividend yield--
Data as of 4:01pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+4.88%
Earnings growth (next 5 years)+12.80%
Revenue growth (last year)+15.38%
P/E ratioNM
Price/Sales7.63
Price/Book1.34

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.17+0.29%
SNYSanofi-0.22-0.57%
NVONovo Nordisk-0.03-0.06%
ABBVAbbVie-0.34-0.52%
Data as of 4:02pm ET, 08/25/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)$3.63
Annual revenue (last year)$15.1B
Annual profit (last year)$3.9B
Net profit margin-19.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs